Related Experiment Video
Updated: Jan 19, 2026

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
Published on: December 30, 2025
Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy
Takashi Horiuchi1, Koichiro Haruki2, Hiroaki Shiba2
1Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan horiuchi@jikei.ac.jp.
Background/Aim:
We aimed to assess surgical outcome and long-term survival after elective hepatic resection for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM) in patients aged 80 years or older.
Patients And Methods:
This study included 100 patients aged 70 years or older, who underwent hepatic resection for HCC or CRLM between January 2000 and December 2012. Outcomes and clinicopathological data were compared between the elderly (aged 70-79 years; n=84) and extremely elderly groups (aged 80 years or over; n=16).
Results:
Incidence of postoperative complications, in-hospital mortality, and postoperative OS in the extremely elderly group were comparable with those of the elderly group. In patients with HCC, the extremely elderly group was associated with shorter DFS (p=0.030) in univariate analysis, while multivariate analysis showed significant and independent factors of cancer recurrence.
Conclusion:
Hepatic resection for HCC and CRLM in patients aged 80 years and over may be safe and acceptable with appropriate selection. For HCC in patients aged 80 years and over, hepatic resection may be effective when negative surgical margins can be achieved.
Related Concept Videos
06:00Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
07:10Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
09:52Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
05:30Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse
05:23Murine Bioluminescent Hepatic Tumour Model

